Pages that link to "Q72669780"

The following pages link to D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats (Q72669780):

Displaying 44 items.

• Discriminative stimulus properties of tianeptine (Q28282272) (← links)
• Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum (Q28512674) (← links)
• Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors (Q28589879) (← links)
• Pharmacological rationale for the clinical use of caffeine (Q34058622) (← links)
• Caffeine use in children: what we know, what we have left to learn, and why we should worry (Q34980128) (← links)
• Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking (Q35206834) (← links)
• Caffeine, fatigue, and cognition (Q35565572) (← links)
• Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. (Q36466181) (← links)
• mGlu5 Receptors and Relapse to Cocaine-Seeking: The Role of Receptor Trafficking in Postrelapse Extinction Learning Deficits (Q36532096) (← links)
• Molecular and pharmacodynamic interactions between caffeine and dopaminergic system (Q36744872) (← links)
• Effects of caffeine on persistence and reinstatement of nicotine-seeking behavior in rats: interaction with nicotine-associated cues (Q36913854) (← links)
• Genetic variance contributes to dopamine receptor antagonist-induced inhibition of sucrose intake in inbred and outbred mouse strains (Q37107329) (← links)
• Potential Role of Caffeine in the Treatment of Parkinson's Disease (Q37129378) (← links)
• Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine (Q37279059) (← links)
• Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice (Q37731456) (← links)
• The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans (Q41527844) (← links)
• Potential role of adenosine antagonist therapy in pathological tremor disorders (Q41639796) (← links)
• D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats (Q41774208) (← links)
• The role of adenosine receptors in the central action of caffeine (Q41819456) (← links)
• Effects of adolescent caffeine consumption on cocaine sensitivity. (Q41964754) (← links)
• Injection of Cocaine-Amphetamine Regulated Transcript (CART) peptide into the nucleus accumbens does not inhibit caffeine-induced locomotor activity: Implications for CART peptide mechanism. (Q42382069) (← links)
• Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation (Q42409901) (← links)
• Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats (Q42447913) (← links)
• Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum (Q42481687) (← links)
• The combined effect of caffeine and ornithine on the mood of healthy office workers (Q43096362) (← links)
• The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum. (Q43180903) (← links)
• The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine (Q43648867) (← links)
• Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats (Q43654312) (← links)
• Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. (Q44660000) (← links)
• Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease (Q44865042) (← links)
• Chronic caffeine intake affects lysozyme activity and immune cells in mice. (Q44895320) (← links)
• Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice (Q46147144) (← links)
• Evodiamine Reduces Caffeine-Induced Sleep Disturbances and Excitation in Mice (Q47647964) (← links)
• Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain (Q48358807) (← links)
• Caffeine--an atypical drug of dependence (Q48405794) (← links)
• Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs (Q48881103) (← links)
• Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys. (Q51447030) (← links)
• Acute and repeated exposure to caffeine: effects on reinstatement of extinguished cocaine-taking behavior in rats. (Q51567117) (← links)
• Modulation by adenosine A2A receptors of dopamine-mediated motor behavior as a basis for antiparkinson?s disease drugs (Q60643597) (← links)
• Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats (Q73815926) (← links)
• Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats (Q73954806) (← links)
• Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors (Q74340020) (← links)
• Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats (Q74578998) (← links)
• Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood (Q88789024) (← links)